By Dr Sarah Larney

Books

Winsley NC; Zador D; Larney S; Dolan K, 2016, Patient motivations, perceptions and experiences of opioid substitution therapy in prison, NDARC Technical Report Number 332, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/Technical%20Report%20Number%20332.pdf

Degenhardt LJ; Gibson G; Leung J; Kumvaj M; Larney S, 2016, Searching the grey literature to access research on illicit drug use, HIV and viral hepatitis A resource to identify drug-related databases and websites, Technical Report Number 334, National Drug and Alcohol Centre, University of New South Wales, Sydney, https://ndarc.med.unsw.edu.au/resource/searching-grey-literature-access-research-illicit-drug-use-hiv-and-viral-hepatitis-resource

Larney S; Toson B; Burns LA; Dolan K, 2011, Opioid substitution treatment in prison and post-release: Effects on criminal recidivism and mortality, Original, National Drug Law Enforcement Research Fund (NDLERF), Canberra, ACT, http://www.ndlerf.gov.au/pub/Monograph_37.pdf

Larney S; Dolan K, 2008, Demand reduction strategies in closed settings in China, Indonesia and Viet Nam, Original, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia

Larney S; Morton P; Dolan K, 2007, Hiv Prevention, Treatment And Care In Prisons In South-East Asia, Original, National Drug and Alcohol Research Centre, University of New, Sydney, NSW, Sydney, http://ndarc.med.unsw.edu.au/NDARCWeb.nsf/resources/TR+288-292/$file/TR290_TOC_ABSTRACT.pdf

Larney S; Matthers B; Dolan K, 2007, Illicit drug treatment in prison: Detoxification, drug-free units, therapeutic communities and opioid substitution treatment, Original, National Drug & Alcohol Research Centre, Randwick, NSW

Journal articles

Gibbs D; Stockings E; Larney S; Bromberg DJ; Shakeshaft A; Farnbach S, 2023, 'The impact of supported accommodation on health and criminal justice outcomes of people released from prison: a systematic literature review', Harm Reduction Journal, 20, http://dx.doi.org/10.1186/s12954-023-00832-8

Høj SB; Minoyan N; Zang G; Larney S; Bruneau J, 2023, 'Gender, sexual orientation identity, and initiation of amphetamine injecting among people who inject drugs: Examination of an expanding drug era in Montreal, Canada, 2011–19', Drug and Alcohol Dependence, 251, http://dx.doi.org/10.1016/j.drugalcdep.2023.110956

Downing BC; Hickman M; Jones NR; Larney S; Sweeting MJ; Xu Y; Farrell M; Degenhardt L; Jones HE, 2023, 'Prevalence of opioid dependence in New South Wales, Australia, 2014–16: Indirect estimation from multiple data sources using a Bayesian approach', Addiction, 118, pp. 1994 - 2006, http://dx.doi.org/10.1111/add.16268

Leung J; Chiu V; Man N; Yuen WS; Dobbins T; Dunlop A; Gisev N; Hall W; Larney S; Pearson SA; Degenhardt L; Peacock A, 2023, 'All-cause and cause-specific mortality in individuals with an alcohol-related emergency or hospital inpatient presentation: A retrospective data linkage cohort study', Addiction, 118, pp. 1751 - 1762, http://dx.doi.org/10.1111/add.16218

Gisev N; Buizen L; Hopkins RE; Schaffer AL; Daniels B; Bharat C; Dobbins T; Larney S; Blyth F; Currow DC; Wilson A; Pearson SA; Degenhardt L, 2023, 'Five-Year Trajectories of Prescription Opioid Use', JAMA Network Open, 6, pp. E2328159, http://dx.doi.org/10.1001/jamanetworkopen.2023.28159

Larney S; Jones NR; Hickman M; Nielsen S; Ali R; Degenhardt L, 2023, 'Does opioid agonist treatment reduce overdose mortality risk in people who are older or have physical comorbidities? Cohort study using linked administrative health data in New South Wales, Australia, 2002–17', Addiction, 118, pp. 1527 - 1539, http://dx.doi.org/10.1111/add.16178

Gisev N; Pearson SA; Dobbins T; Buizen L; Murphy T; Wilson A; Blyth F; Dunlop A; Larney S; Currow DC; Mattick RP; Degenhardt L, 2023, 'Cohort profile: POPPY II - A population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia', BMJ Open, 13, pp. e068310, http://dx.doi.org/10.1136/bmjopen-2022-068310

Borschmann R; Keen C; Spittal M; Pirkis J; Preen D; Rosen D; Larney S; Young J; Kinner S, 2023, 'High risk of death from multiple causes following release from incarceration: an individual participant data meta-analysis of 1,471526 adults in eight countries', Population Medicine, 5, http://dx.doi.org/10.18332/popmed/165135

Marshall AD; Martinello M; Zolopa C; Treloar C; Larney S, 2023, 'Universal hepatitis C virus screening and treatment as part of prenatal care', The Lancet Gastroenterology and Hepatology, 8, pp. 295 - 297, http://dx.doi.org/10.1016/S2468-1253(22)00421-6

Syangbo A; Hickman M; Colledge-Frisby S; Leung J; Grebely J; Larney S; Degenhardt L; Trickey A, 2023, 'Associations between the prevalence of chronic hepatitis B among people who inject drugs and country-level characteristics: An ecological analysis', Drug and Alcohol Review, 42, pp. 569 - 581, http://dx.doi.org/10.1111/dar.13595

Jiang N; Bruneau J; Makarenko I; Minoyan N; Zang G; Høj SB; Larney S; Martel-Laferrière V, 2023, 'HCV treatment initiation in the era of universal direct acting antiviral coverage – Improvements in access and persistent barriers', International Journal of Drug Policy, 113, pp. 103954, http://dx.doi.org/10.1016/j.drugpo.2023.103954

Martin NK; Beletsky L; Linas BP; Bayoumi A; Pollack H; Larney S, 2023, 'Modeling as Visioning: Exploring the Impact of Criminal Justice Reform on Health of Populations with Substance Use Disorders.', MDM Policy Pract, 8, pp. 23814683231202984, http://dx.doi.org/10.1177/23814683231202984

Zolopa C; Brothers TD; Leclerc P; Mary JF; Morissette C; Bruneau J; Hyshka E; Martin NK; Larney S, 2022, 'Changes in supervised consumption site use and emergency interventions in Montréal, Canada in the first twelve months of the COVID-19 pandemic: An interrupted time series study', International Journal of Drug Policy, 110, http://dx.doi.org/10.1016/j.drugpo.2022.103894

Minoyan N; Høj SB; Zolopa C; Vlad D; Bruneau J; Larney S, 2022, 'Self-reported impacts of the COVID-19 pandemic among people who use drugs: a rapid assessment study in Montreal, Canada', Harm Reduction Journal, 19, http://dx.doi.org/10.1186/s12954-022-00620-w

Bharat C; Gisev N; Barbieri S; Dobbins T; Larney S; Farrell M; Degenhardt L, 2022, 'Trends in opioid analgesic utilisation among people with a history of opioid dependence', Drug and Alcohol Dependence, 238, http://dx.doi.org/10.1016/j.drugalcdep.2022.109548

Bharat C; Gisev N; Barbieri S; Dobbins T; Larney S; Farrell M; Degenhardt L, 2022, 'The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.', International Journal of Population Data Science, 7, http://dx.doi.org/10.23889/ijpds.v7i3.1954

Jones N; Degenhardt L; Hickman M; Nielsen S; Larney S; Dobbins T; Ali R, 2022, 'The impact of opioid agonist treatment on fatal and non-fatal drug overdose among people with a history of opioid dependence in NSW, Australia, 2001-2018: findings from the OATS retrospective linkage study.', International Journal of Population Data Science, 7, http://dx.doi.org/10.23889/ijpds.v7i3.1787

Zolopa C; Høj SB; Minoyan N; Bruneau J; Makarenko I; Larney S, 2022, 'Ageing and older people who use illicit opioids, cocaine or methamphetamine: a scoping review and literature map', Addiction, 117, pp. 2168 - 2188, http://dx.doi.org/10.1111/add.15813

Vo AT; Patton T; Peacock A; Larney S; Borquez A, 2022, 'Illicit Substance Use and the COVID-19 Pandemic in the United States: A Scoping Review and Characterization of Research Evidence in Unprecedented Times', International Journal of Environmental Research and Public Health, 19, http://dx.doi.org/10.3390/ijerph19148883

Jones NR; Hickman M; Nielsen S; Larney S; Dobbins T; Ali R; Degenhardt L, 2022, 'The impact of opioid agonist treatment on fatal and non-fatal drug overdose among people with a history of opioid dependence in NSW, Australia, 2001–2018: Findings from the OATS retrospective linkage study', Drug and Alcohol Dependence, 236, http://dx.doi.org/10.1016/j.drugalcdep.2022.109464

Colledge-Frisby S; Jones N; Larney S; Peacock A; Lewer D; Brothers TD; Hickman M; Farrell M; Degenhardt L, 2022, 'The impact of opioid agonist treatment on hospitalisations for injecting-related diseases among an opioid dependent population: A retrospective data linkage study', Drug and Alcohol Dependence, 236, http://dx.doi.org/10.1016/j.drugalcdep.2022.109494

Zolopa C; Burack JA; O’Connor RM; Corran C; Lai J; Bomfim E; DeGrace S; Dumont J; Larney S; Wendt DC, 2022, 'Changes in Youth Mental Health, Psychological Wellbeing, and Substance Use During the COVID-19 Pandemic: A Rapid Review', Adolescent Research Review, 7, pp. 161 - 177, http://dx.doi.org/10.1007/s40894-022-00185-6

Vuong T; Gillies M; Larney S; Montebello M; Ritter A, 2022, 'The association between involuntary alcohol treatment and subsequent emergency department visits and hospitalizations: a Bayesian analysis of treated patients and matched controls', Addiction, 117, pp. 1589 - 1597, http://dx.doi.org/10.1111/add.15755

Larney S; Madden A; Marshall AD; Martin NK; Treloar C, 2022, 'A gender lens is needed in hepatitis C elimination research', International Journal of Drug Policy, 103, http://dx.doi.org/10.1016/j.drugpo.2022.103654

Chaillon A; Bharat C; Stone J; Jones N; Degenhardt L; Larney S; Farrell M; Vickerman P; Hickman M; Martin NK; Bórquez A, 2022, 'Modeling the population-level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, Australia', Addiction, 117, pp. 1338 - 1352, http://dx.doi.org/10.1111/add.15736

Warfield SC; Bharat C; Bossarte RM; DePhilippis D; Farrell M; Hoover M; Larney S; Marshalek P; McKetin R; Degenhardt L, 2022, 'Trends in comorbid opioid and stimulant use disorders among Veterans receiving care from the Veterans Health Administration, 2005–2019', Drug and Alcohol Dependence, 232, http://dx.doi.org/10.1016/j.drugalcdep.2022.109310

Tse WC; Djordjevic F; Borja V; Picco L; Lam T; Olsen A; Larney S; Dietze P; Nielsen S, 2022, 'Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a ‘moral hazard’ associated with naloxone supply', International Journal of Drug Policy, 100, http://dx.doi.org/10.1016/j.drugpo.2021.103513

Curtis M; Berk J; Larney S; Rich JD; Stoové M, 2022, 'Switching of opioid agonist treatment modality during imprisonment: A novel marker for increased support need during and following release from prison', International Journal of Drug Policy, 100, http://dx.doi.org/10.1016/j.drugpo.2021.103572

Nielsen S; Larney S, 2022, 'Commentary on Glanz et al.: Longer buprenorphine treatment duration is associated with lower rates of opioid overdose, but can we address barriers to staying in treatment?', Addiction, http://dx.doi.org/10.1111/add.16032

Gibbs D; Grebely J; Sutherland R; Larney S; Butler K; Dietze PM; Starr M; Peacock A, 2021, 'Concordance between self-reported and current hepatitis C virus infection status in a sample of people who inject drugs in Sydney and Canberra, Australia', Drug and Alcohol Review, 40, pp. 1349 - 1353, http://dx.doi.org/10.1111/dar.13282

Gibbs D; Price O; Grebely J; Larney S; Sutherland R; Read P; Butler K; Degenhardt L; Peacock A, 2021, 'Hepatitis C virus cascade of care among people who inject drugs in Australia: Factors associated with testing and treatment in a universal healthcare system', Drug and Alcohol Dependence, 228, http://dx.doi.org/10.1016/j.drugalcdep.2021.109050

Curtis M; Larney S; Higgs P; Cossar RD; Winter RJ; Stewart AC; Stoové M, 2021, 'Initiation of Medications for Opioid Use Disorder Shortly Before Release From Prison to Promote Treatment Retention: Strong Evidence but Compromised Policy', Journal of Addiction Medicine, 15, pp. 525 - 526, http://dx.doi.org/10.1097/ADM.0000000000000788

Bharat C; Larney S; Barbieri S; Dobbins T; Jones NR; Hickman M; Gisev N; Ali R; Degenhardt L, 2021, 'The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15-year retrospective cohort study', Addiction, 116, pp. 3139 - 3152, http://dx.doi.org/10.1111/add.15514

Bharat C; Degenhardt L; Dobbins T; Larney S; Farrell M; Barbieri S, 2021, 'Using administrative data to predict cessation risk and identify novel predictors among new entrants to opioid agonist treatment', Drug and Alcohol Dependence, 228, http://dx.doi.org/10.1016/j.drugalcdep.2021.109091

Borschmann R; Tibble H; Spittal M; Preen D; Pirkis J; Larney S; Rosen D; Young J; Kinner S, 2021, '535The epidemiology of all-cause and cause-specific mortality following release from prison in 11 countries', International Journal of Epidemiology, 50, http://dx.doi.org/10.1093/ije/dyab168.091

Larney S; Jones H; Rhodes T; Hickman M, 2021, 'Mapping drug epidemiology futures', International Journal of Drug Policy, 94, http://dx.doi.org/10.1016/j.drugpo.2021.103378

Grebely J; Tran L; Degenhardt L; Dowell-Day A; Santo T; Larney S; Hickman M; Vickerman P; French C; Butler K; Gibbs D; Valerio H; Read P; Dore GJ; Hajarizadeh B, 2021, 'Association between Opioid Agonist Therapy and Testing, Treatment Uptake, and Treatment Outcomes for Hepatitis C Infection among People Who Inject Drugs: A Systematic Review and Meta-analysis', Clinical Infectious Diseases, 73, pp. E107 - E118, http://dx.doi.org/10.1093/cid/ciaa612

Ferraro CF; Stewart DE; Grebely J; Tran LT; Zhou S; Puca C; Hajarizadeh B; Larney S; Santo T; Higgins JPT; Vickerman P; Degenhardt L; Hickman M; French CE, 2021, 'Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta-analysis', Addiction, 116, pp. 1664 - 1676, http://dx.doi.org/10.1111/add.15316

Zolopa C; Hoj S; Bruneau J; Meeson JS; Minoyan N; Raynault MF; Makarenko I; Larney S, 2021, 'A rapid review of the impacts of “Big Events ” on risks, harms, and service delivery among people who use drugs: Implications for responding to COVID-19', International Journal of Drug Policy, 92, http://dx.doi.org/10.1016/j.drugpo.2021.103127

Peacock A; Tran LT; Larney S; Stockings E; Santo T; Jones H; Santomauro D; Degenhardt L, 2021, 'All-cause and cause-specific mortality among people with regular or problematic cocaine use: a systematic review and meta-analysis', Addiction, 116, pp. 725 - 742, http://dx.doi.org/10.1111/add.15239

Stone J; Degenhardt L; Grebely J; Larney S; Altice FL; Smyrnov P; Rahimi-Movaghar A; Alavi M; Young AM; Havens JR; Miller WC; Hickman M; Vickerman P, 2021, 'Modelling the intervention effect of opioid agonist treatment on multiple mortality outcomes in people who inject drugs: a three-setting analysis', The Lancet Psychiatry, 8, pp. 301 - 309, http://dx.doi.org/10.1016/S2215-0366(20)30538-1

Nielsen S; Sanfilippo P; Picco L; Bruno R; Kowalski M; Wood P; Larney S, 2021, 'What predicts pharmacists’ engagement with opioid-outcome screening? Secondary analysis from an implementation study in community pharmacy', International Journal of Clinical Pharmacy, 43, pp. 420 - 429, http://dx.doi.org/10.1007/s11096-020-01074-5

Jones NR; Nielsen S; Farrell M; Ali R; Gill A; Larney S; Degenhardt L, 2021, 'Retention of opioid agonist treatment prescribers across New South Wales, Australia, 2001–2018: Implications for treatment systems and potential impact on client outcomes', Drug and Alcohol Dependence, 219, http://dx.doi.org/10.1016/j.drugalcdep.2020.108464

Warfield SC; Pack RP; Degenhardt L; Larney S; Bharat C; Ashrafioun L; Marshall BDL; Bossarte RM, 2021, 'The next wave? Mental health comorbidities and patients with substance use disorders in under-resourced and rural areas', Journal of Substance Abuse Treatment, 121, http://dx.doi.org/10.1016/j.jsat.2020.108189

Back to profile page